EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age-Dependent Safety and Effectiveness of Pridinol Versus NSAIDs in Acute (Low) Back Pain: A Secondary Analysis of the Providence Real-World Study

Michael A Überall iD, Artur Schikowski, Philipp C G Müller-Schwefe iD

Journal of Clinical Medicine · 23.06.2026 · 15 (13) · 4888

DOI: 10.3390/jcm15134888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.06.2026. Verfasst von Michael A Überall und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Health Care Research, Institute of Neurological Sciences-IFNAP, Nordostpark 51, 90411 Nürnberg, Germany. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strathmann (Germany).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely recommended for the treatment of acute (low) back pain, despite modest effectiveness and well-known safety concerns, particularly in older patients. Pridinol is a centrally acting antispasmodic with a mechanism-oriented approach targeting muscle spasm, a key component of acute back pain. While a previous real-world analysis demonstrated a significantly better tolerability and effectiveness of pridinol compared with NSAIDs, age-dependent effects have not yet been systematically evaluated.

Objective

To assess the age dependency of effectiveness, safety, and tolerability of pridinol versus NSAIDs in patients with acute (low) back pain under real-world conditions, based on already available data.

Methods

This secondary analysis used propensity score-matched real-world data from the German Pain e-Registry (PROVIDENCE study; EUPAS identifier: 49718). A total of 934 patients with acute (low) back pain treated for four weeks with either pridinol (n = 467) or NSAIDs (n = 467) were stratified by age (

Schlagwörter

Stichwörter der Autor:innen

acute low back painadverse drug reactionsage-related risknonsteroidal anti-inflammatory drugspridinolreal-world evidence

Autor:innen und Institutionen

  • Center of Excellence in Health Care Research, Institute of Neurological Sciences-IFNAP, Nordostpark 51, 90411 Nürnberg, Germany.
  • Pain Institute & Center for Medical Education Düsseldorf, Friedrichstraße 13-15, 40217 Düsseldorf, Germany.
  • Interdisciplinary Pain and Palliative Care Center Göppingen, Schillerplatz 8/1, 73033 Göppingen, Germany.

ORCID-Profile: Michael A Überall, Philipp C G Müller-Schwefe

Förderung

  • Strathmann (Germany)

Zitieren

APA

Überall, M. A., Schikowski, A., & Müller-Schwefe, P. C. G. (2026). Age-Dependent Safety and Effectiveness of Pridinol Versus NSAIDs in Acute (Low) Back Pain: A Secondary Analysis of the Providence Real-World Study. Journal of Clinical Medicine, 15(13), 4888. https://doi.org/10.3390/jcm15134888

Vancouver

Überall MA, Schikowski A, Müller-Schwefe PCG. Age-Dependent Safety and Effectiveness of Pridinol Versus NSAIDs in Acute (Low) Back Pain: A Secondary Analysis of the Providence Real-World Study. Journal of Clinical Medicine. 2026;15(13):4888. doi:10.3390/jcm15134888

BibTeX
@article{berall2026,
  author = {Überall, Michael A and Schikowski, Artur and Müller-Schwefe, Philipp C G},
  title = {Age-Dependent Safety and Effectiveness of Pridinol Versus NSAIDs in Acute (Low) Back Pain: A Secondary Analysis of the Providence Real-World Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {13},
  pages = {4888},
  doi = {10.3390/jcm15134888}
}
Kostenlos starten →